Adenoid basal carcinoma cervix - A rare epithelial neoplasm.
Journal
Journal of cancer research and therapeutics
ISSN: 1998-4138
Titre abrégé: J Cancer Res Ther
Pays: India
ID NLM: 101249598
Informations de publication
Date de publication:
23 Sep 2024
23 Sep 2024
Historique:
received:
22
05
2023
accepted:
08
08
2023
medline:
21
9
2024
pubmed:
21
9
2024
entrez:
21
9
2024
Statut:
aheadofprint
Résumé
Adenoid basal carcinoma of the uterine cervix is a rare epithelial neoplasm. Adenoid basal carcinoma constitutes less than 1% of all cervical adenocarcinomas and has a favorable prognosis. Adenoid basal carcinoma is assumed to arise from a multipotential basal or reserve cell layer in the cervical epithelium. We report a case of adenoid basal carcinoma of the uterine cervix with complaints of bleeding per vagina in a 40-year-old female. The carbohydrate antigen 125 level was elevated (100 U/ml), and the MRI abdomen and pelvis revealed increased signal intensity in the anterior lip of the cervix. The local examination revealed thickening of the anterior lip of the cervix and induration in the left fornix. The patient was diagnosed with carcinoma cervix stage IB2 (FIGO Stage). The patient was operated by a radical robotic hysterectomy. Microscopic examination revealed small basaloid tumor cell nests with peripheral cell palisading and microcyst formation. The tumor cells showed p63 immunoreactivity in basaloid tumor cells and were negative for CD117 and S-100P. This tumor should be differentiated from adenoid basal cell hyperplasia, which has a favorable outcome, and adenoid cystic carcinoma, with a dismal course.
Identifiants
pubmed: 39305461
doi: 10.4103/jcrt.jcrt_1176_23
pii: 01363817-990000000-00105
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Copyright: © 2024 Journal of Cancer Research and Therapeutics.
Références
Chen TD, Chuang HC, Lee LY. Adenoid basal carcinoma of the uterine cervix:Clinicopathologic features of 12 cases with reference to CD117 expression. Int J Gynecol Pathol 2012;31:25–32.
Brainard JA, Hart WR. Adenoid basal epitheliomas of the uterine cervix:A reevaluation of distinctive cervical basaloid lesions currently classified as adenoid basal carcinoma and adenoid basal hyperplasia. Am J Surg Pathol 1998;22:965–75.
Kerdraon O, Cornélius A, Farine MO, Boulanger L, Wacrenier A. Adenoid basal hyperplasia of the uterine cervix:A lesion of reserve cell type, distinct from adenoid basal carcinoma. Hum Pathol 2012;43:2255–65.
Senzaki H, Osaki T, Uemura Y, Kiyozuka Y, Ogura E, Okamura A, et al. Adenoid basal carcinoma of the uterine cervix:Immunohistochemical study and literature review. Jpn J Clin Oncol 1997;27:437–41.
Goyal A, Wang Z, Przybycin CG, Yang B. Application of p16 immunohistochemistry and RNA in situ hybridization in the classification of adenoid basal tumors of the cervix. Int J Gynecol Pathol 2016;35:82–91.
Yoshida T, Fujiwara K, Lchiro Kohno MS, Mikami Y, Manabe T. Adenoid basal carcinoma of the cervix uteri:A case report. Pathology International 1997;47. 11. 775777.